MARSHALL WACE, LLP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$173,000
-46.1%
152,671
-29.9%
0.00%
-100.0%
Q2 2022$321,000
-66.0%
217,815
-47.1%
0.00%
-50.0%
Q1 2022$943,000
+193.8%
412,031
+670.5%
0.00%
+100.0%
Q3 2021$321,000
-71.4%
53,474
-76.8%
0.00%
-80.0%
Q2 2021$1,122,000
+36.0%
230,441
-31.0%
0.01%
+25.0%
Q1 2021$825,000
-79.5%
334,108
-25.7%
0.00%
-84.6%
Q4 2016$4,021,000
+44.8%
449,820
+181.1%
0.03%
+30.0%
Q3 2016$2,776,000
+147.4%
160,0000.0%0.02%
+122.2%
Q2 2016$1,122,000160,0000.01%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders